Welcome to Celdryl

We are a targeted cell permeability company in its formation stages, and our primary markets are cancer and arthritic joints.

We have been selected as finalists in the San Diego TCA Quick Pitch competition, October 2, 2008.

For more information please click here: Quick Pitch

For general information on Celdryl please email us.